Thin basement membrane disease overview: Difference between revisions

Jump to navigation Jump to search
Line 19: Line 19:
[[Thin basement membrane disease]] is an [[inherited disorder]] caused by [[mutation]] in [[COL4A3]], [[COL4A4]] and rarely [[COL4A5]] [[gene mutation]]. Some form of [[TBMD]] are due to '<nowiki/>'''[[De novo]]'''' [[mutation]].
[[Thin basement membrane disease]] is an [[inherited disorder]] caused by [[mutation]] in [[COL4A3]], [[COL4A4]] and rarely [[COL4A5]] [[gene mutation]]. Some form of [[TBMD]] are due to '<nowiki/>'''[[De novo]]'''' [[mutation]].


==Differentiating Xyz from Other Diseases==
==Differentiating thin basement membrane disease from Other Diseases==
As a common cause of several [[glomerulopathies]], [[Persistent]] [[hematuria]] must be differentiated as [[benign]] cause of [[thin basement membrane disease]] from other life threatening caueses of [[glomerular]] bleeding including [[Alport syndrome]], [[IgA nephropathy]], [[lupus nephritis]], [[postinfectious glomerulonephritis]].


==Epidemiology and Demographics==
==Epidemiology and Demographics==

Revision as of 19:36, 24 October 2020

Thin basement membrane disease Microchapters

Home

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Thin basement membrane disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Thin basement membrane disease overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Thin basement membrane disease overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Thin basement membrane disease overview

CDC on Thin basement membrane disease overview

Thin basement membrane disease overview in the news

Blogs on Thin basement membrane disease overview

Directions to Hospitals Treating Thin basement membrane disease

Risk calculators and risk factors for Thin basement membrane disease overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Thin basement membrane disease (TBMD) is one of the inherited disorder of kidney affecting glomeruli. It is also known as Thin basement membrane nephropathy (TBMN) or thin membrane nephropathy or thin GBM syndrome or benign familial hematuria or benign familial essential hematuria or congenital hereditary hematuria or hereditary hematuria or familial hematuric nephritis or benign hereditary nephritis. Being the most frequent cause of familial hematuria TBMD is affecting 1% of population.[1] 40% of TBMD is caused by germline mutation in COL4A3, COL4A4 genes, but female carrier with COL4A5 mutation may develop TBMD. [2]

Historical Perspective

Thin basement membrane disease is the most common cause of Persistent recurrent hematuria. A form of Benign hemorrhagic nephritis is first noted in 1926 by Goerge Baehr. ThenPersistent recurrent hematuria is first observed in seven out of eight siblings in a family by Melvin I. Marks and Keith N. Drummond in 1969. P. W. Rogers was the first one to analyse the association between recurrent asymptomatic hematuria and thin glomerular basement membrane in 1973. The association between the COL4A3, COL4A4 and COL4A5 gene mutation in long q arm of chromosome 2 and the recurrence of X-linked and autosomal alport syndrome in several studies conducted in 1990-1994. In 1996, it was demonstrated that the cause of Benign familial hematuria is Mutation in COL4A3 and COL4A4.

Classification

There is no distinctive classification on Thin basement membrane disease.

Pathophysiology

Thin basement membrane disease is usually caused by Heterozygous mutation in COL4A3 and COL4A4 gene in autosomal nonprogressive dominant pattern and heterozygous mutation in COL4A5 gene in X-chromosome may cause Thin basement membrane disease in female.. Alport syndrome, IgA nephropathy are among the most common to have association with Thin basement membrane disease. Gross pathology usually shows no distinctive features although Diffuse thinning of GBM in electron microscopy, Erythrocytes in between renal tubules ad bowman's membrane, Minimal glomerular change or mesangial expansion on light microscopy are seen on microscopic histopathological analysis.

Causes

Thin basement membrane disease is an inherited disorder caused by mutation in COL4A3, COL4A4 and rarely COL4A5 gene mutation. Some form of TBMD are due to 'De novo' mutation.

Differentiating thin basement membrane disease from Other Diseases

As a common cause of several glomerulopathies, Persistent hematuria must be differentiated as benign cause of thin basement membrane disease from other life threatening caueses of glomerular bleeding including Alport syndrome, IgA nephropathy, lupus nephritis, postinfectious glomerulonephritis.

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

References

  1. Savige J, Rana K, Tonna S, Buzza M, Dagher H, Wang YY (October 2003). "Thin basement membrane nephropathy". Kidney Int. 64 (4): 1169–78. doi:10.1046/j.1523-1755.2003.00234.x. PMID 12969134.
  2. Buzza M, Wilson D, Savige J (May 2001). "Segregation of hematuria in thin basement membrane disease with haplotypes at the loci for Alport syndrome". Kidney Int. 59 (5): 1670–6. doi:10.1046/j.1523-1755.2001.0590051670.x. PMID 11318937.

Template:WH Template:WS